<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGas</journal-id><journal-title-group><journal-title>Open Journal of Gastroenterology</journal-title></journal-title-group><issn pub-type="epub">2163-9450</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgas.2021.1111024</article-id><article-id pub-id-type="publisher-id">OJGas-113181</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Profile of Endoscopic Lesions and Prevalence of &lt;i&gt;H. pylori&lt;/i&gt; Infection at the Digestive Endoscopy Unit of Panzi General Reference Hospital in Bukavu
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Nteranya</surname><given-names>Musole Adonis</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bwemere</surname><given-names>Mungwete Josue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Motcheyo</surname><given-names>Chepig Hyacinthe</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tchass</surname><given-names>Chasinga</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cimanya</surname><given-names>Cubaka Fortunat</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abedi</surname><given-names>Zalufa Marlène</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bihehe</surname><given-names>Masemo Dieudonné</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kasereka</surname><given-names>Kikwaya Jerry</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Malamba</surname><given-names>Lez Didier</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Vangossum</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>University Clinic of Lubumbashi, Service of Internal Medicine, Lubumbashi, Congo (DRC)</addr-line></aff><aff id="aff2"><addr-line>Faculty of Medecine, Evangelic University of Africa, Bukavu, Congo (DRC)</addr-line></aff><aff id="aff5"><addr-line>UHC Saint Pierre, Service of Gastroenterology, Bruxelles, Belgium</addr-line></aff><aff id="aff3"><addr-line>Medical Center of the Community, Service of Radiology, Lubumbashi, Congo (DRC)</addr-line></aff><aff id="aff1"><addr-line>Panzi General Reference Hospital, Service of Internal Medicine, Bukavu, Congo (DRC)</addr-line></aff><pub-date pub-type="epub"><day>03</day><month>11</month><year>2021</year></pub-date><volume>11</volume><issue>11</issue><fpage>230</fpage><lpage>243</lpage><history><date date-type="received"><day>10,</day>	<month>September</month>	<year>2021</year></date><date date-type="rev-recd"><day>13,</day>	<month>November</month>	<year>2021</year>	</date><date date-type="accepted"><day>16,</day>	<month>November</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: 
  Thanks to the opening of the digestive endoscopy unit in the Reference General Hospital of Panzi in Bukavu in the Democratic Republic of the Congo, which inspired our work on the profile of endoscopic lesions observed in a series of 1000 patients correlated with clinical and demographic criteria with the contribution of pathology examinations of the 292 biopsies performed. The aim of our work is to evaluate the prevalence of significant endoscopic lesions as well as that of H. pylori infection. <b>Material and Methods:</b> This is a retrospective, descriptive and analytical study, ranging from the 16<sup>th</sup> of December 2014 to the 16<sup>th</sup> of June 2016. It covered 1000 patients who benefited from a high digestive endoscopy and 292 of them had a biopsy with pathological examination. The data obtained were recorded and analyzed using the Epi-info software and chi-square test. <b>Results:</b> fifty-five percent of these patients were women.
   
  66% of the patients were under 50
   
  years of age. Their major symptom was epigastric pain
   
  (89.2%),
   
  the most observed endoscopic lesion was erythematous gastritis
   
  (82%) therefore we have noticed 21
  .
  5% of significant lesions. Gastric cancer was present in 3.9% of cases and gastric ulcer in 4.2% of cases. The gastric tumor was correlated with age and sex (P-value at 0.000 and 0.013). The gastroduodenal ulcer was linked to age, NSAID and tobacco use (P-value at 0.0007, 0.001, 0.007). Esophageal mycosis was correlated with HIV status (P-value at 0.000). Helicobacter pylori gastritis was the most frequent (61.30%) and
   
  Helicobacter pylori
   were present in 63% of gastric biopsies. <b>Conclusion: </b>Upper digestive endoscopy is a major tool for the diagnosis of upper gastrointestinal disorders and should always be followed by a biopsy if there is a suspicious lesion for pathologic confirmation and adequate management.
 
</p></abstract><kwd-group><kwd>High Digestive Endoscopy</kwd><kwd> Lesion</kwd><kwd> &lt;i&gt;H. pylori&lt;/i&gt;</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Access to health care is limited in the South-Kivu region because of insufficient medical supply and the precariousness of the population [<xref ref-type="bibr" rid="scirp.113181-ref1">1</xref>]. Therefore, some paraclinical examinations remain essential in the diagnostic process and care in our environment like upper digestive endoscopy.</p><p>The advent of endoscopy, more particularly gastroscopy, has revolutionized the diagnosis of oeso-gastroduodenal diseases [<xref ref-type="bibr" rid="scirp.113181-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.113181-ref3">3</xref>]. In France, for example, B. Moulinier and Ph. Grenier Boley report that, in 85% of cases of upper gastrointestinal bleeding, emergency endoscopy could provide valuable information concerning either the diagnosis by direct observation of the lesion or the location of the bleeding which can guide the surgical procedure [<xref ref-type="bibr" rid="scirp.113181-ref4">4</xref>]. In Japan, Shin et al. reported having detected 14,436 neoplastic lesions by endoscopy over a period of 13 years [<xref ref-type="bibr" rid="scirp.113181-ref5">5</xref>].</p><p>In Africa even if digestive endoscopy remains little established, it remains of great diagnostic contribution for pathologies of the digestive tract. In Benin for example, out of 930 esogastroduodenal endoscopies performed in 18 months at the National Hospital and University Center (CNHU) of Cotonou 1992, 91% of these revealed lesions [<xref ref-type="bibr" rid="scirp.113181-ref6">6</xref>].</p><p>In Lom&#233;, Lawson-Ananissoh et al. in 2014 performed upper digestive endoscopy in 2795 patients and observed 3485 lesions distributed as follows: inflammatory pathology predominated (56.3%), ulcerative pathology (13.89%), tumor pathology (2.01%) [<xref ref-type="bibr" rid="scirp.113181-ref7">7</xref>].</p><p>It should be noted that upper gastrointestinal fibroscopy is often coupled with biopsy of the gastric and/or duodenal mucosa in order not only to make an anatomopathological diagnosis of the lesions observed on endoscopy but also to look for the presence of Helicobacter pylori.</p><p>In the Democratic Republic of Congo and particularly in Bukavu, there are very few studies on endoscopic lesions observed in the environment and even less on the prevalence of Helicobacter pylori infection. This is why it seemed opportune in this work to draw up a succinct picture of endoscopic lesions as observed in our daily practice and as well as the contribution of pathological anatomy on digestive pathology and the role of H. pylori in digestive affections. Therefore, this work pursues the following objectives:</p><p>- Determine the frequency of different endoscopic lesions in our environment.</p><p>- Give the influence of certain demographic parameters on the occurrence of these lesions.</p><p>- To determine the etiology of gastric and duodenal lesions at histology.</p></sec><sec id="s2"><title>2. Material and Methods</title><sec id="s2_1"><title>2.1. Study Framework</title><p>We carried out this study in the digestive endoscopy service and the pathological anatomy service of the Panzi General Reference Hospital, a University Hospital managed by the medical works of the 8th Pentecostal Community in Central Africa (8th CEPAC), part of the Churches of Christ in the Congo. It is located in Ibanda Township, Panzi district, on Mushununu Avenue 8 kilometers from the city center, south side, and about 700 meters from the Bukavu-Uvira national road, in the city of Bukavu in the Democratic Republic of the Congo.</p></sec><sec id="s2_2"><title>2.2. Materials</title><p>The study population consisted of all the patients coming for an upper gastrointestinal endoscopy during the entire study period from the 16<sup>th</sup> of December 2014 to the 16<sup>th</sup> of June 2016. We had a number of 1000 patients whose age varies from 1 year to 95 years with a median of 42 years of which 292 biopsies were available.</p></sec><sec id="s2_3"><title>2.3. Methods</title><sec id="s2_3_1"><title>2.3.1. Type and Period of Study</title><p>This is a retrospective, descriptive and single-center analytical study involving 1000 patients who underwent upper gastrointestinal endoscopy with a FUJI video endoscope EG-200 and a 2500 series processor. Of these patients, 292 received a biopsy for pathological analysis (affordability).</p></sec><sec id="s2_3_2"><title>2.3.2. Inclusion Criteria</title><p>- All patients who underwent upper gastrointestinal endoscopy during the study period.</p><p>- All patients who have had the necessary means for accessibility to the pathological anatomy examination.</p><p>- We defined as significant lesions: esophageal varices, benign esophageal strictures, esophageal tumor, gastric tumor and gastro-duodenal ulcer.</p></sec><sec id="s2_3_3"><title>2.3.3. Exclusion Criteria</title><p>- All patients with only a colonoscopy and a rectoscopy.</p><p>- All patients who have had a control upper gastrointestinal endoscopy.</p><p>- All patients on treatment of proton pump inhibitors.</p></sec><sec id="s2_3_4"><title>2.3.4. Parameters Analyzed</title><p>- Demographic criteria: age (&#177;50 years), sex, consumption of tobacco, non- steroidal anti-inflammatory drugs (NSAIDs), and HIV status.</p><p>- Clinical criteria: epigastralgia, heartburn, vomiting, gastrointestinal bleeding, weight loss, dysphagia.</p><p>- Endoscopic lesions: esophageal varices, benign esophageal strictures, peptic ulcers, esogastric cancers.</p><p>- Anatomopathological criteria: the staining technique was carried out as follows:</p><p>1) The gastric biopsy sample is stored in 10% formalin.</p><p>2) The sample will be dehydrated with ethanol for one hour and then lightened with xylol for 30 minutes and finally an impregnation with liquid paraffin for one hour.</p><p>3) Embed the tissues in a paraffin block which will be cut with a microtome.</p><p>4) Make a microtome cut.</p><p>5) Do the staining itself with HEMATOXYLINE EOSIN to establish the pathological diagnosis:</p><p>- Harris hematoxylin bath for 2 minutes.</p><p>- rinse in running water quickly.</p><p>- acid alcohol bath for 1 mn (bleach).</p><p>- lithiumcarbonate bath for 1 mn.</p><p>- rinse with running water quickly.</p><p>- 1% eosin bath for 2 minutes.</p><p>6) To color with GIEMSA for the research of Helicobacter pylori:</p><p>- The Giemsahistological kit is used or else the Giemsa used in parasitology is diluted to 1/10th.</p><p>- Cover the slide containing gastric tissue for five minutes then wash and dry.</p><p>- The reading will be done under a microscope at magnifications between 40&#215; and 100&#215;.</p><p>NB: All these steps can be carried out in part automatically using a PLC.</p></sec></sec><sec id="s2_4"><title>2.4. Data Analysis</title><p>All the data collected were entered and analyzed using the Epi-software Info version 7.1.3.3 and Excel software version 2013. The Chi-Square test was used to compare our results which were significant for a probability P &lt; 0.05. Our results will be presented in raw form, either in the form of tables or figures.</p></sec></sec><sec id="s3"><title>3. Results</title><p>The study population consisted of all the patients coming for an upper gastrointestinal endoscopy during the entire study period. We had a number of 1000 patients among which 450 men and 550 women whose age varies from 1 year to 95 years with a median of 42 years of which 292 biopsies were available. Then we are going to describe here endoscopic lesions of 1000 patients but the pathological examination of samples concerns only 292 biopsies available.</p><sec id="s3_1"><title>3.1. Sociodemographic Criteria</title><sec id="s3_1_1"><title>3.1.1. Sex</title><p>The following figure (<xref ref-type="fig" rid="fig1">Figure 1</xref>) shows the distribution of patients by sex.</p><p>This graph shows that more women came to the consultation (55%) compared to men (45%).</p></sec><sec id="s3_1_2"><title>3.1.2. Age</title><p><xref ref-type="fig" rid="fig2">Figure 2</xref> below shows the distribution of patients by age.</p><p>This graph shows us the very high percentage of people under 50 who came to the consultation (66%) compared to those over 50 (34%).</p></sec></sec><sec id="s3_2"><title>3.2. Clinical Criteria</title><sec id="s3_2_1"><title>3.2.1. Symptoms Involved</title><p><xref ref-type="fig" rid="fig3">Figure 3</xref> below shows the distribution of patients according to symptoms.</p><p>From this graph, we can see that the dominant symptom in consultation was epigastralgia (89.2%), followed by vomiting (6.8%), Gastro-intestinal bleeding (5.8%), Heartburn (5.5%), Loss of weight (4.9%) and at last dysphagia (2.2%). We have to mention that we could notice some patients showing many of these symptoms at the same time.</p></sec><sec id="s3_2_2"><title>3.2.2. Endoscopic Lesions Observed</title><p><xref ref-type="fig" rid="fig4">Figure 4</xref> below shows the distribution of patients according to the endoscopic lesions observed.</p><p><xref ref-type="fig" rid="fig4">Figure 4</xref> shows that inflammatory pathologies were the lesions most frequently encountered on endoscopy among which gastritis (82%), esophagitis</p><p>(60%). Ulcerative pathologies come at the second time, gastric ulcers (4.7%), Duodenal ulcers (7.2%) and tumors come at the third, gastric tumor (3.9%), Esophageal tumor (0.7%). We then noticed 21.5% of significant lesions (esophageal varices, benign esophageal strictures, esophageal tumor, gastric tumor and gastro-duodenal ulcer).</p></sec></sec><sec id="s3_3"><title>3.3. Correlation with Demographic and Clinical Data</title><p><xref ref-type="table" rid="table1">Table 1</xref> below shows the correlation between gastric tumor and age.</p><p>We note that the gastric tumor was correlated with age over 50 years with a P-value &lt; 0.001 that is 8.4% of people over 50 with gastric tumor and 1.3% of people under the age of 50 with gastric tumor.</p><p>It emerges from this table that the gastric tumor was significantly associated with the male sex with a P-value of 0.013. That is 5.6% men with gastric tumor and 2.5% women with gastric tumor (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>From this table, it emerges that the tumor of the esophagus was correlated with the male sex with a P-value equal to 0.029. That is 1.3% of men with esophagic</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Gastric tumor with age</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Gastric tumor</th></tr></thead><tr><td align="center" valign="middle" >Age</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >&lt;50 years</td><td align="center" valign="middle" >626 (98.7%)</td><td align="center" valign="middle" >8 (1.3%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;50 years</td><td align="center" valign="middle" >336 (91.6%)</td><td align="center" valign="middle" >31 (8.4%)</td><td align="center" valign="middle" >&lt;0.001** S</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >962 (96.1%)</td><td align="center" valign="middle" >39 (3.9%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>S: Significant.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Gastric tumor with sex</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Gastric tumor</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >538 (97.5%)</td><td align="center" valign="middle" >14 (2.5%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >422 (94.4%)</td><td align="center" valign="middle" >25 (5.6%)</td><td align="center" valign="middle" >0.013** S</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >962 (96.1%)</td><td align="center" valign="middle" >39 (3.9%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>S: Significant.</p><p>tumor and 0.2% women with esophagic tumor (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>We note that peptic ulcer disease was correlated with age greater than 50 years with a P-value equal to 0.007. What means 5.4% of people over 50 having gastro-duodenal ulcer against 4.2% of people under the age of 50 having that same disease (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>From this table it clearly emerges that peptic ulcer was associated with NSAIDs consumption (P-value of 0.001) and smoking (P-value of 0.007). 14.3% of ulcers were noticed among patients taking NSAIDs and 25% of ulcers were noticed among patients taking Tobacco. In some patients, we noticed both NSAIDs and Tobacco consumption (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>This table (<xref ref-type="table" rid="table6">Table 6</xref>) shows us that esophageal varices are significantly associated with the male sex with a P-value of 0.049. This means 5.6% men with esophageal varices and 3.1% women.</p><p>We can see from this table (<xref ref-type="table" rid="table7">Table 7</xref>) that mycosis of the esophagus was correlated with HIV status with a P-value &lt; 0.001. That is 63.3% of mycosis was observed in HIV patients and 1% of mycosis only in HIV-negative people.</p></sec><sec id="s3_4"><title>3.4. Anatomo-Pathological Criteria</title><sec id="s3_4_1"><title>3.4.1. Distribution of Cases According to Anatomo-Pathological Diagnosis</title><p>It emerges from this figure (<xref ref-type="fig" rid="fig5">Figure 5</xref>) that Helicobacter pylori gastritis was the most described lesion either 61.30% compared to chronic non-specific gastritis 28.77%. Gastric adenocarcinoma was observed in 3.42% of cases.</p></sec><sec id="s3_4_2"><title>3.4.2. Breakdown of Cases by Presence or Not of Helicobacter pylori</title><p>This figure (<xref ref-type="fig" rid="fig6">Figure 6</xref>) shows a high prevalence of Helicobacter pylori 63% on the biopsy samples taken.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Esophagic tumor with sex</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Esophagic tumor</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >551 (99.8%)</td><td align="center" valign="middle" >1 (0.2%)</td><td align="center" valign="middle" >0.029** S</td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >441 (98.7%)</td><td align="center" valign="middle" >6 (1.3%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >992 (99.3%)</td><td align="center" valign="middle" >7 (0.7%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>S: Significant.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Gastro-Duodenal ulcer with age</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Gastro-duodenal Ulcer</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >&lt;50 years</td><td align="center" valign="middle" >529 (95.8%)</td><td align="center" valign="middle" >23 (4.2%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;50 years</td><td align="center" valign="middle" >423 (94.6%)</td><td align="center" valign="middle" >24 (5.4%)</td><td align="center" valign="middle" >0.007** S</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >952 (95.3%)</td><td align="center" valign="middle" >47 (4.7%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>S: Significant.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Gastro-Duodenal ulcer with age</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Variables</th><th align="center" valign="middle"  rowspan="2"  ></th><th align="center" valign="middle"  colspan="2"  >Gastro-duodenal Ulcer</th><th align="center" valign="middle"  rowspan="2"  >P-value</th></tr></thead><tr><td align="center" valign="middle"  colspan="2"  >No n (%) Yes n (%)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >NSAIDs consumption</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >900 (95.8%)</td><td align="center" valign="middle" >39 (4.2%)</td><td align="center" valign="middle"  rowspan="2"  >0.001** S</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >48 (85.7%)</td><td align="center" valign="middle" >8 (14.3%)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >948 (95.3%)</td><td align="center" valign="middle" >47 (4.7%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Tobacco consumption</td><td align="center" valign="middle" >No</td><td align="center" valign="middle" >945 (96.1%)</td><td align="center" valign="middle" >45 (3.9%)</td><td align="center" valign="middle"  rowspan="2"  >0.007** S</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >6 (75.0%)</td><td align="center" valign="middle" >2 (25.0%)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >951 (95.3%)</td><td align="center" valign="middle" >47 (4.7%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> esophageal varices with sex</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Esophageal varices</th></tr></thead><tr><td align="center" valign="middle" >Sex</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >535 (96.9%)</td><td align="center" valign="middle" >17 (3.1%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >422 (94.6%)</td><td align="center" valign="middle" >25 (5.6%)</td><td align="center" valign="middle" >0.049**</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >957 (95.8%)</td><td align="center" valign="middle" >42 (4.2%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Mycosis of esophagus with HIV status</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="4"  >Mycosis of Esophagus</th></tr></thead><tr><td align="center" valign="middle" >HIV status</td><td align="center" valign="middle" >No n (%)</td><td align="center" valign="middle" >Yes n (%)</td><td align="center" valign="middle" >P-value</td></tr><tr><td align="center" valign="middle" >Negative</td><td align="center" valign="middle" >959 (99.0%)</td><td align="center" valign="middle" >10 (1.0%)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Positive</td><td align="center" valign="middle" >11 (26.7%)</td><td align="center" valign="middle" >19 (63.3%)</td><td align="center" valign="middle" >&lt;0.001** S</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >970 (92.8%)</td><td align="center" valign="middle" >29 (7.2%)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec></sec></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Limitations of the Study</title><p>This work was based only on the sample of patients referred to us for digestive endoscopy which represents only a few parts of the population suffering from digestive disorders because not everyone can pay for the exam. We would like to have an idea of the role of Helicobacter pylori in the occurrence of digestive lesions but we have been limited by the sample (292) of biopsies analyzed in pathology which might have underestimated the real prevalence of H. Pylori in our area. We then hope that in the future some other studies with big sample sizes will be necessary in order to fix the problem correctly. This work was a single-center analytical study, though our results match with the majority of studies as we can see further in the discussion, there is a need to have the reality of all the hospitals that perform digestive endoscopy in our area for more conclusive results.</p></sec><sec id="s4_2"><title>4.2. Sociodemographic Criteria</title><sec id="s4_2_1"><title>4.2.1. The Sex</title><p>In our study, we noticed that more women (55%) came for consultation compared to men (45%). Our results are different from those of Ibara et al. at Brazzaville who received 50.73% of men and 49.26% of women in consultation [<xref ref-type="bibr" rid="scirp.113181-ref8">8</xref>]. However, our results are similar to those of Lawson-Ananissoh et al. in Togo in 2014 which received 57.49% of women in consultation compared to 42.51% [<xref ref-type="bibr" rid="scirp.113181-ref7">7</xref>].</p><p>This result could be explained by the fact that women are more inclined to come for consultation at the first sign.</p></sec><sec id="s4_2_2"><title>4.2.2. Age</title><p>We noticed a very high percentage of people under 50 in consultation (66%) compared to those over 50 (34%). Our results are superimposable on those of Lawson-Ananissoh et al. in Togo where the most represented age group was between 25 years and 44 years old [<xref ref-type="bibr" rid="scirp.113181-ref7">7</xref>].</p><p>This could be explained by the structure of the population of developing countries with a high proportion of young subjects in the population.</p></sec></sec><sec id="s4_3"><title>4.3. Clinical Criteria</title><sec id="s4_3_1"><title>4.3.1. The Symptoms Involved</title><p>In our series, we found that the dominant symptom in the consultation was epigastralgia (89.2%). Our results join those of Ndjitoyap Ndam et al. in Cameroon in whom epigastralgia (52.77%) represented half of the symptoms [<xref ref-type="bibr" rid="scirp.113181-ref9">9</xref>]; as well as those of Hountondjia et al. in Benin who noted 43.55% of epigastralgia [<xref ref-type="bibr" rid="scirp.113181-ref6">6</xref>]. The results of Lawson-Ananissoh et al. in Togo go in the same direction with a frequency of epigastralgia at 60.68% [<xref ref-type="bibr" rid="scirp.113181-ref7">7</xref>].</p></sec><sec id="s4_3_2"><title>4.3.2. Endoscopic Lesions Observed</title><p>Our series shows that inflammatory pathologies were the leading lesions encountered on endoscopy. Ulcerative pathologies came second with gastric ulcers at 4.7% and duodenal ulcers at 7.2%. Finally, cancerous pathologies are in third place with gastric cancers at 3.9% and esophageal cancer at 0.7%.</p><p>Our results corroborate those of Ndjitoyap Ndam et al. who found a predominance of inflammatory pathologies at 54.65%, followed by ulcer pathologies at 31.65% and finally tumor pathologies at 2.97% [<xref ref-type="bibr" rid="scirp.113181-ref9">9</xref>]. The results of Lawson-Ana- nissoh et al. go in the same direction with a predominance of inflammatory pathology at 56.3%; followed by ulcer pathology at 13.89% and finally tumor pathology at 2.01%.</p><p>This high predominance of inflammatory pathology in tropical environments could be related to the Helicobacter pylori infection which is very widespread in developing countries, but also with the multiple aggressive factors for the gastric mucosa, in particular self-medication with products gastro-toxic, and bad eating habits.</p></sec></sec><sec id="s4_4"><title>4.4. Correlation of Demographic and Clinical Data</title><sec id="s4_4_1"><title>4.4.1. Gastric Tumor with Age</title><p>We notice that the gastric tumor is significantly associated with age greater than 50 years with a P-value equal to 0.000, this corroborates the results of Ibar et al. who found a mean age of onset of the gastric tumor at 51.1 years [<xref ref-type="bibr" rid="scirp.113181-ref8">8</xref>]; as well as those of Hountondjia et al. in whom the majority of patients with gastric tumor were aged between 55 and 69 years [<xref ref-type="bibr" rid="scirp.113181-ref6">6</xref>]. Diarra et al. in Mali in 2014 joined us with an average age of onset of gastric tumor at 56.51 years [<xref ref-type="bibr" rid="scirp.113181-ref10">10</xref>]. Bougougla et al. in Togo in 2014 are not left with an average age of onset of gastric tumor at 58.8 years [<xref ref-type="bibr" rid="scirp.113181-ref11">11</xref>], as well as Mellouki et al. in Morocco in 2014 who found an average age of onset at 58 years [<xref ref-type="bibr" rid="scirp.113181-ref12">12</xref>].</p><p>All this could be explained by the fact of the infection with Helicobacter pylori which was recognized as a type I carcinogen by the international agency for research on cancer in 1994 [<xref ref-type="bibr" rid="scirp.113181-ref13">13</xref>] and involved in around 80% of stomach cancers [<xref ref-type="bibr" rid="scirp.113181-ref14">14</xref>] after almost 30 years of evolution of the infection [<xref ref-type="bibr" rid="scirp.113181-ref15">15</xref>].</p></sec><sec id="s4_4_2"><title>4.4.2. Gastric Tumor with Sex</title><p>Our analysis showed that gastric tumor was significantly correlated with male sex with a P-value of 0.013. Our results join those of Mellouki et al. in Morocco in 2014 who found a clear male predominance with a P-value of less than 0.05 [<xref ref-type="bibr" rid="scirp.113181-ref12">12</xref>], as well as those of Diarra et al. who found a sex ratio of 1.6 in favor of men [<xref ref-type="bibr" rid="scirp.113181-ref10">10</xref>]. The male predominance was also found by Bougougla et al. who found a sex ratio of 2.5 in favor of men [<xref ref-type="bibr" rid="scirp.113181-ref11">11</xref>].</p><p>This distribution would be due to more frequent consumption of tobacco in males in our environment and constitutes a cofactor of gastric carcinogenesis.</p></sec><sec id="s4_4_3"><title>4.4.3. Esophagus Tumor with Sex</title><p>Our series highlights the fact that the esophageal tumor was significantly correlated with the male sex with a P-value equal to 0.029. This result is superimposable on that of Hountondjia et al. who found that the tumor of the esophagus was the prerogative of humans (21 out of 25 cases) [<xref ref-type="bibr" rid="scirp.113181-ref6">6</xref>].</p><p>All of this could be explained by chronic alcoholism and smoking, which are common in humans and which are risk factors for cancer of the esophagus.</p></sec><sec id="s4_4_4"><title>4.4.4. Gastroduodenal Ulcer with Age</title><p>We note in our series that peptic ulcer was significantly correlated with age greater than 50 years with a P-value equal to 0.007. But our results do not match those of Diarra et al. in Bamako in 2009 who found that the most represented age group was between 30 years and 49 years old with a rate of 47.8% [<xref ref-type="bibr" rid="scirp.113181-ref16">16</xref>]. Ibar et al. noted an average age of 41.33 years [<xref ref-type="bibr" rid="scirp.113181-ref17">17</xref>].</p><p>This discrepancy can be explained by the fact that the peptic ulcer is the result of the imbalance between the stressors and the protective factors of the stomach; the occurrence of these factors is not dependent on age.</p></sec><sec id="s4_4_5"><title>4.4.5. Gastroduodenal Ulcer with Tobacco and NSAIDs</title><p>It was clear from our study that peptic ulcer disease was significantly correlated with taking NSAIDs (P-value of 0.001) and smoking (P-value of 0.007).</p><p>Our results agree with those of Ibar et al., who found smoking in 16% of patients and taking NSAIDs in 46% of ulcer patients, thus being major sources of peptic ulcer disease [<xref ref-type="bibr" rid="scirp.113181-ref17">17</xref>].</p><p>All this could be explained by the fact that NSAIDs are drugs that are heavily consumed in self-medication. These drugs produce a weakening of the mucous membrane defenses which can promote, reactivate or complicate the ulcer.</p></sec><sec id="s4_4_6"><title>4.4.6. Esophagian Varices with Sex</title><p>Our series showed that esophageal varices were significantly correlated with male sex with a P-value of 0.049. Our result corroborates that of Lawson-Ananissoh et al. in Togo who found an association of male esophageal varices with a P-value of 0.000 [<xref ref-type="bibr" rid="scirp.113181-ref7">7</xref>].</p><p>This result could be explained by the fact that esophageal varices are endoscopic signs of portal hypertension, the main cause of which is cirrhosis, which affects both men and women [<xref ref-type="bibr" rid="scirp.113181-ref18">18</xref>].</p></sec><sec id="s4_4_7"><title>4.4.7. Mycosis of Esophagus with HIV Status</title><p>We note from our study that mycosis of the esophagus was significantly correlated with HIV status with a P-value of 0.000, which is 63% of seropositive patients.</p><p>Our results are close to those of Ngatcha et al. in Rabat in 2014 who found, out of a total of 68 seropositive, 19 cases of mycotic esophagitis, which is 37% of cases [<xref ref-type="bibr" rid="scirp.113181-ref19">19</xref>].</p><p>All this is explained by the fact thatCandida albicans are the main cause of opportunistic infections of the esophagus in HIV. Patients often develop dysphagia and odynophagia [<xref ref-type="bibr" rid="scirp.113181-ref20">20</xref>].</p></sec></sec><sec id="s4_5"><title>4.5. Distribution of Cases According to the Presence or Not of Helicobacter pylori</title><p>In our series, the presence of Helicobacter pylori was 63% of cases. Our results are superimposable on those of Essadik et al. in 2013 in Casablanca with a prevalence of H. pylori of 69.2% [<xref ref-type="bibr" rid="scirp.113181-ref21">21</xref>]. Ankouane et al. in 2013 in Yaound&#233; found a prevalence of 72.5% [<xref ref-type="bibr" rid="scirp.113181-ref22">22</xref>]. Ilboudo et al. in Ouagadougou found an even higher prevalence, 81.3% [<xref ref-type="bibr" rid="scirp.113181-ref23">23</xref>].</p><p>This high prevalence of H. Pylori in these developing countries is explained by the precarious sanitary conditions, great promiscuity, ignorance of the infection and often limited access to treatment [<xref ref-type="bibr" rid="scirp.113181-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.113181-ref25">25</xref>] [<xref ref-type="bibr" rid="scirp.113181-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.113181-ref27">27</xref>].</p></sec></sec><sec id="s5"><title>5. Conclusions</title><p>The objectives of our study were not only to determine the frequency of different endoscopic lesions in our environment and to give the influence of certain demographic parameters on the occurrence of certain lesions but also to determine the relative prevalence of Helicobacter pylori infection in our sample and its relation to certain endoscopic lesions.</p><p>Our study which was retrospective, descriptive and analytical going from the 16<sup>th</sup> of December 2014 to 16<sup>th</sup> of June 2016 led to the following conclusions:</p><p>- The major symptom that prompted patients to come to the hospital was 89.2% epigastralgia.</p><p>- During upper gastrointestinal endoscopy, we observed 21.5% of significant lesions.</p><p>- Gastric cancer was quite common in our environment (3.9%).</p><p>- The gastric tumor was significantly correlated with age and sex and was the correlation of esophageal tumor to sex.</p><p>- Peptic ulcer disease was significantly correlated with age, tobacco use and NSAIDs.</p><p>- Mycosis of the esophagus was significantly correlated with HIV status.</p><p>On histology, the presence of Helicobacter pylori was effective in 63% of cases.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Adonis, N.M., Josue, B.M., Hyacinthe, M.C., Chasinga, T., Fortunat, C.C., Marl&#232;ne, A.Z., Dieudonn&#233;, B.M., Jerry, K.K., Didier, M.L. and Marc, V. (2021) Profile of Endoscopic Lesions and Prevalence of H. pylori Infection at the Digestive Endoscopy Unit of Panzi General Reference Hospital in Bukavu. Open Journal of Gastroenterology, 11, 230-243. https://doi.org/10.4236/ojgas.2021.1111024</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113181-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Van Gossum, M., Adonis, N.M., Steve, N., et al. (2017) Epidemiological Profile of Lesions Observed in the Service of Gastroenterology at the Panzi General Reference Hospital-Bukavu-South-Kivu, DRC. Congress Palace, Paris, 181 p.https://snfge.org/thematiques/imagerie?page=7</mixed-citation></ref><ref id="scirp.113181-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Heyries, L., Durieux, O., Mirabel T., et al. (2017) Imaging of Non-Tumor Pathology of the Stomach and Duodenum. https://em-consulte.com/article/23111/imagerie-de-la-pathologie-non-tumorale-de-l-estomac</mixed-citation></ref><ref id="scirp.113181-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Barriere, E., Courat, L., Sautereau, D., et al. (2017) Diagnostic and Therapeutic Endoscopy of the Upper Digestive Tract. https://.em-consulte.com/article/20040/endoscopie-diagnostique-et-thérapeutique-du-tracus-digestif</mixed-citation></ref><ref id="scirp.113181-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Moulinier, B. and Boley, G. (1982) Interest of Emergency Gastroscopy in Upper Digestive Hemorrhages. Acta Endoscopica, 1, 9-12.</mixed-citation></ref><ref id="scirp.113181-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Shin, K., Kusaka, H., Yamano, H., et al. (1999) Characteristics of Depressed Early Colorectal Carcinoma (Abstract). Gastrointestinal Endoscopy, 49, AB63.</mixed-citation></ref><ref id="scirp.113181-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Hountondjia, K. and Addra, B. (1992) Contribution of Endoscopy to the Diagnosis of Oeso-Gastroduodenal Affections in Tropical Environments. Beninese Experience with 930 Examinations. Black African Medicine, 39, 337-344.</mixed-citation></ref><ref id="scirp.113181-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Lawson-Ananissoh, L.M., Bouglouga, O., Bagny, A. and Kaaga, L. (2014) Upper Gastrointestinal Endoscopy in 2795 Patients at the University Campus Hospital of Lomé: Peculiarities According to Sex. The Pan African Medical Journal, 19, Article No. 262. https://doi.org/10.11604/pamj.2014.19.262.4512</mixed-citation></ref><ref id="scirp.113181-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Ibara, J.R., Moukassa, B. and Itoua-Ngaporo, A. (1993) Upper Digestive Pathology in Congo. Medecine d’Afrique Noire, 40, 97-100.</mixed-citation></ref><ref id="scirp.113181-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ndjitoyap Ndam, E.C., Njoya, O., Mballa, E., et al. (1990) Upper Digestive Endoscopy in Cameroon. Medecine d’Afrique Noire, 37, 453-456.</mixed-citation></ref><ref id="scirp.113181-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M.T., Konate, A., Diarra, A.N., et al. (2014) The Epidemiological and Prognostic Characteristics of Stomach Cancer in Urban Areas in Mali. Mali Medical, 29, 50-54.</mixed-citation></ref><ref id="scirp.113181-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Bougougla, O., Lawson-Ananissoh, L.M., Bagny, A., Kaaga, L. and Amegbor, K. (2015) Stomach Cancer: Epidemiological, Clinical and Histological Aspects at the Lomé Campus CHU (Togo). Tropical Medicine and Health, 25, 65-68.</mixed-citation></ref><ref id="scirp.113181-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Azevedo, N.F., Guimaraes, N., Figueiredo, C., et al. (2007) A New Model for the Transmission of Helicobacter pylori: Role of Environmental Reservoirs as Gene Pools to Increase Strain Diversity. Critical Reviews in Microbiology, 33, 157-169.https://doi.org/10.1080/10408410701451922</mixed-citation></ref><ref id="scirp.113181-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Magalhaes Queiroz, D.M. and Luzza, F. (2006) Epidemiology of Helicobacter pylori Infection. Helicobacter, 11, 1–5.</mixed-citation></ref><ref id="scirp.113181-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Vale, F.F. and Vítor, J.M.B. (2010) Transmission Pathway of Helicobacter pylori: Does Food Play a Role in Rural and Urban Areas? International Journal of Food Microbiology, 138, 1-12. https://doi.org/10.1016/j.ijfoodmicro.2010.01.016</mixed-citation></ref><ref id="scirp.113181-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Nurgalieva, Z., Malaty, H., Graham, D., et al. (2002) Helicobacter pylori Infection in Kazakhstan: Effect of Water Source and Household Hygiene. The American Journal of Tropical Medicine and Hygiene, 67, 201-206. https://doi.org/10.4269/ajtmh.2002.67.201</mixed-citation></ref><ref id="scirp.113181-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ilboudo, D., Sangaré, L., Sanou, J., et al. (1997) Epidemiological and Clinical Aspects of Helicobacter pylori Infection in Tropical Areas. Medecine d’Afrique Noire, 44, 24-28.</mixed-citation></ref><ref id="scirp.113181-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Ankouane, F., Noah, D., Tagni-Sartre, M., et al. (2013) Epidemiology of Helicobacter pylori Infection in Yaoundé: From the Peculiarity to the African Enigma. The Pan African Medical Journal, 16, Article ID: 115.</mixed-citation></ref><ref id="scirp.113181-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Essadik, A., Benomar, H., Rafik, I., et al. (2013) Epidemiological and Clinical Aspects of Helicobacter pylori Infection in a Moroccan Study. Hegel, 3, 163-169.</mixed-citation></ref><ref id="scirp.113181-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Alyoune, M. and Biadillah, M. (1991) Digestive Disorders of AIDS. Médecine du Maghreb, 25, 5-9.</mixed-citation></ref><ref id="scirp.113181-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Ngatcha, G., Kabbaj, N., Salihoun, M., et al. (2014) Gastro-Intestinal Lesions in Patients with Acquired Immunodeficiency Syndrome. Hegel, 4, 22-27. https://doi.org/10.4267/2042/53500</mixed-citation></ref><ref id="scirp.113181-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Guy, J. and Peters, M. (2013) Liver Disease in Women: The Influence of Gender on Epidemiology, Natural History and Patient Outcomes. Gastroenterology &amp; Hepatology, 9, 633-639.</mixed-citation></ref><ref id="scirp.113181-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Ibara, J.R., Moukassa, B. and Itoua-Ngaporo, A. (1993) Gastric and Duodenal Ulcers in Brazzaville. Medecine d’Afrique Noire, 40, 459-465.</mixed-citation></ref><ref id="scirp.113181-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Diarra, M.T., Konate, A., Traore, C., et al. (2009) Gastro-Duodenal Ulcers in Rural Areas in Mali. Mali Medical, 24, 1-3.</mixed-citation></ref><ref id="scirp.113181-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Courillon-Mallet, A. (2009) Helicobacter pylori and Gastric Cancer: Eradication to Prevent Cancer? Gastroentérologie Clinique et Biologique, 33, 301-305. https://doi.org/10.1016/j.gcb.2009.02.007</mixed-citation></ref><ref id="scirp.113181-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">INCA (2014) Risk Factors for Stomach Cancer. http://www.e-cancer.fr/cancerinfo/Patients-et-proches/Les-cancer/cancer-de-l-estomac/facteurs-de-risques</mixed-citation></ref><ref id="scirp.113181-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">IARC (1994) Schistosomes, Liver Flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 7-14 June 1994, 177-240.</mixed-citation></ref><ref id="scirp.113181-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Mellouki, I., et al. (2014) Epidemiology of Gastric Cancer: Experience of a Moroccan Hospital Center. The Pan African Medical Journal, 17, Article ID: 42.</mixed-citation></ref></ref-list></back></article>